In this context, we have observed a significant reduction of COL1A1 and TGFB1 gene expressions through the addition of 2 μM amphotericin B in our fibrosis model with primary NHDFs supplemented with TGF-β1. The gene discussed is TGFB1; the disease is fibrosis.